Bcl-2 immunoreactive cells with immature neuronal phenotype exist in the nonepileptic adult human brain

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 2, 2000, Pages 113-119

  Yachnis, Anthony T ^a   Roper, Steven N ^a   Love, Alix ^a   Fancey, Jason T ^a   Muir, David ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Amygdala; Hamartia; Neurogenesis; Nuclear antigen; Tubulin

Indexed keywords

PROTEIN BCL 2;

ADULT; AGED; ARTICLE; BRAIN DEVELOPMENT; CELL DEATH; EPILEPSY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; PHENOTYPE; PRIORITY JOURNAL;

EID: 0033983091     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.2.113     Document Type: Article

References (29)

1. Davies AM. The bcl-2 family of proteins and the regulation of neuronal survival. TINS 1995;18:355-58
2. Reed JC. Double identity for proteins of the bcl-2 family. Nature 1997;387:773-76
3. Allsopp TE, Wyatt S, Paterson HF. Davies AM. The protooncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 1993;73:295-307
4. Zhoung L-T, Sarafian T. Kane DJ, et al. Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci 1993,90:4533-37
5. Martinou JC, Dubois-Dauphin M. Staple JK, et al. Overexpression of bcl-2 in transgenic mice protects neurons from naturally occuring cell death and experimental ischemia. Neuron 1994,13:1017-30
6. Farlie PG, Dringen R, Rees SM, Kannouralis G, Bernard O. Bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc Natl Acad Sci 1995;92:4397-4401
7. Dubois-Dauphin M, Frakowski H, Tsujimoto Y. Huarte J, Martinou J-C. Neonatal motoneurons ovcrcxpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc Natl Acad Sci 1994;91:3309-13
8. Raghupathi R, Fernandez SC, Murai H, et al. Bcl-2 overexpression attenuates cortical cell loss after traumatic brain injury. J Cerebr Blood Flow Metabol 1998;18:1259-69
9. Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ. Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult peripheral nervous system. Development 1994,120:301-11
10. Veis-Novack D, Korsmeyer SJ. Bcl-2 protein expression during murine development. Am J Pathol 1994;145:61-73
11. Shimohama S, Fujimoto S, Sumida Y, Tanino H. Differential expression of rat brain bcl-2 family proteins in development and aging. Biochem Biophys Res Com 1998;252:92-96
12. Yachnis AT, Powell SZ, Olmsted JJ, Eskin TA. Distinct neurodevelopmental patterns of bcl-2 and bcl-x expression are altered in glioneuronal hamartias of the human temporal lobe. J Neuropathol Exp Neurol 1997;56:186-98
13. Yachnis AT, Giovanini MA, Eskin TA, Reier PJ, Anderson DK. Developmental patterns of bcl-2 and bcl-x polypeptide expression in the human spinal cord. Exp Neurol 1998;150:82-97
14. Motoyama N, Wang F, Roth KA, et al. Massive cell death of immature hemutopoetic cells and neurons in Bcl-x-deficient mice. Science 1995;267:1506-10
15. Parsadanian AS, Cheng Y, Keller-Peck CR, Holtzman DM, Snider WD. Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons. J Neurosci 1998;18:1009-19
16. Wolf HK, Wellmer J, Muller MB, Wiestler OD, Hufnagel A, Pietsch T. Glioneuronal malformative lesions and dysembryoplastic neurocpithelial tumors in patients with chronic pharmacoresistant epilepsies. J Neuropathol Exp Neurol 1995;54:245-54
17. Kasper BS, Stefan H. Buchfelder M, Paulus W. Temporal lobe microdysgenesis in epilepsy versus control brains. J Neuropathol Exp Neurol 1999;58:22-28
18. Pezzella F, Tse AG, Cordell JL, Pulford KAF, Gatter KC, Mason DY. Expression of the bcl-2 oncogene protein is not specific for the t(14;18) chromosomal translocation. Am J Pathol 1990;137:225-32
19. Yachnis AT, Fancey JT, Eskin TA. Bcl-2 immunostaining identifies "hamartias" of the caudal amygdala in non-epileptic patients. (Abstract) J Neuropathol Exp Neurol 1998;57:514
20. Yachnis AT, Trojanowski JQ. Studies of childhood brain tumors using immunohistochemistry and microwave technology: Methodological considerations. J Neurosci Meth 1994;55:191-200
21. Gloor P. The temporal lobe and limbic system. New York: Oxford University Press, 1997:591-721
22. Sorvari H. Soininen H, Paljarvi L, Karkola K, Pitkanen A. Distribution of parvalbumin- immunoreactive fibers in the human amygdaloid complex. J Comp Neurol 1995;185-212
23. Wolf HK, Muller MB, Spanle M, Zentner J, Schramm J, Wiestler OD. Ganglioglioma: A detailed histopathological and immunohistochemical analysis of 61 cases. Acta Neuropathol 1994;88:166-73
24. Sarnat HB, Nochlin D, Born DE. Neuronal nuclear antigen (NeuN): A marker of neuronal maturation in early human fetal nervous system. Brain Dev 1998;20:88-94
25. Katsetos CD, Frankfurter A, Chrstakos S, Mancall EL, Vlachos IN, Urich H. Differential localisation of class III beta-tubulin isotype and calbindin-D28k defines distinct neuronal types in developing human cerebellar cortex. J Neuropathol Exp Neurol 1993;52:655-66
26. Lee MK, Tuttle JB, Rebhun LI, Cleveland DW, Frankfurter A. The expression and posttranslational modification of a neuron-specific beta-tubulin isotype during chick embryogenesis. Cell Motil Cytoskel 1990;17:118-32
27. Easter SS, Ross LS, Frankfurter A. Initial tract formation in the mouse brain. J Neurosci 1993;13:285-99
28. Bernier PJ, Parent A. Bcl-2 as a marker of neuronal immaturity in postnatal primate brain. J Neurosci 1998;18:2486-97
29. Bernier PJ, Parent A. The anti-apoptosis bcl-2 proto-oncogene is preferentially expressed in limbic structures of the primate brain. Neuroscience 1998;82:635-40